Tagomics
Tagomics' proprietary multiomic platform unlocks disease-associated biomarkers from a range of biological sources including genetic, epigenetic, and fragmentomic features. In combination with our advanced bioinformatic and machine learning approaches our platform provides unique biological insights and offers a step change in genomics-based disease profiling and diagnosis.
Latest Content
Industry Insight
Targeting the Unmethylated Genome: A New Approach to Epigenetic Profiling
Researchers from Tagomics, the University of Birmingham, and the Van Andel Institute have developed “Active-Seq”, a novel enzymatic platform for epigenomic analysis that requires just a fraction of the sequencing depth of traditional approaches.
Industry Insight
Academic Origins Driving Impact in Epigenetic Diagnostics
An epigenetic analysis platform spun out of academia could address current issues with wider adoption of epigenetic profiling as a cancer diagnostic tool. Hear about the challenges, successes and importance of industry partners.
Product News
Tagomics Announces a Multiomic Profiling Co-Marketing Agreement With Agilent
Exclusive program will provide customers with a single, unified workflow for comprehensive genomic profiling and genome-wide epigenetic analysis.
Advertisement
